We propose a visual response assessment method for FDG-PET in head and neck cancer.
It is based on a five-point grading scale, assessed by multidisciplinary consensus reading.
This system is simple, oncologically meaningful and likely to be reproducible.
Response assessment during and after radiotherapy by this system can predict outcomes.
Our system can be used in a clinical trial setting to standardise reporting.